RASEF and breast cancer: Further, to determine whether RASEF downregulation accounted for the anti-proliferative effect of NCOA2 depletion, we assessed breast cancer cell growth after RASEF knockdown in MTS cell proliferation (Figure 5D) and colony formation (Figure 5E) assays.